Anebulo plans going-private via reverse split; $3.50/share for fractional shares, 91% premium

Anebulo Pharmaceuticals, Inc.

• Reverse stock split ratio range 1-for-2,500 to 1-for-7,500; stockholder vote at special meeting Aug 22, 2025.
• Cash payment of $3.50 per pre-split share for fractional shares, representing a 91% premium to July 22 close.
• Holders below 2,500-7,500 pre-split shares will be cashed out; holders above retain one post-split share per minimum.
• Transaction aims to reduce record holders below 300 to terminate SEC registration; board may abandon at any time.
• Company cites high cost of being public as burdensome; will focus on advancing selonabant IV formulation.